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SYNOPSIS 
 
     The thesis entitled “Synthetic studies towards the common polyketide fragment 
of Hoiamides, Azumamide-E analogues, 1,2,3-triazoles and peptidofoldamers” 
has been divided into four chapters.  
 
CHAPTER-I : Chapter I describes an introduction to bio-active natural cyclic 
depsipeptides and synthesis of the common polyketide 
fragment of hoiamides. 
CHAPTER-II : Chapter II describes an introduction to histone deacetylase 
(HDAC) inhibitors and synthesis of Azumamide-E analogues. 
CHAPTER-III : Chapter-III is further divided into two sections (Section-A and 
Section-B).   
SECTION-A : This section describes introduction to benzyne precursor (2-
(trimethylsilyl) phenyl trifluoromethanesulfonate) and synthesis 
of benzotriazoles via azide-benzyne cycloaddition in a single 
step manner. 
SECTION-B : This section describes the synthesis of triazolo-benzoxazepine 
derivatives and their biological evaluation. 
CHAPTER-IV : Chapter IV describes introduction to peptidofoldamers and   
synthesis of oligomers of trans β-norbornene amino acid. 
 
 
Chapter I:  
This chapter describes an introduction to bio-active natural cyclic depsipeptides 
and synthesis of the common polyketide fragment of hoiamides.  
      
     The natural products hoiamide A and B are cyclic depsipeptides, whereas hoiamide 
C is a linear compound. The structural complexity of these molecules includes 15 
asymmetric carbons, peptide link and three thiazole rings. The common structural 
feature in all three natural products is the polyketide fragment ie C30-C40 of hoiamide 
A, C31-C41 of hoiamide B and C21-C31 of hoiamide C (Figure 1). 
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     In continuation of our work in the synthesis of marine cyclic peptides,
 
we were 
interested in the synthesis of hoiamides. Herein, we present synthesis of the 
polyketide fragment 4 (Figure 2) of hoiamides. 
 
 
 
Our retrosynthetic analysis (Scheme 1) showed that fragment 4 could be derived 
from thiazolidine system 5, which in turn is envisioned from Crimmins aldol adduct 
6. Adduct 6 in turn could arise from the known 1,-3- diol, 7 which can be obtained 
from propane -1,-3-diol (8) (Scheme 1). 
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Results and Discussion 
     Initially, 1, 3-propane diol (8) was treated with KOH and benzyl bromide to afford 
benzyloxy propane 1-ol, followed by conversion of other primary alcohol to aldehyde 
using IBX in DMSO/THF and resultent aldehyde was converted to α, β-unsaturated 
ester 9. The ester functionality was reduced using AlH3 in THF at 0 
o
C to afford allyl 
alcohol 10 in 76% yield. The allylic alcohol 10 upon Sharpless asymmetric 
epoxidation with L-(+) –diethyl tartarate, titanium (IV) isopropoxide and TBHP in 
CH2Cl2 at -20 
o
C afforded the corresponding epoxide 11 in 97% yield (Scheme 2).  
 
 
     The epoxy alcohol 11 was subjected to regioselective opening with MeLi, CuI 
furnished a mixture of 1,3-diol 7 and 1,2-diol. 1,2-Diol was removed by oxidative 
cleavage with NaIO4 in THF:H2O (7:3), further 1,3-diol was easily separated by 
column chromatography in 60% yield. Selective protection of the primary alcohol 
group in 7 with TBDMS-Cl, Et3N, in CH2Cl2 afforded its silyl ether 12 in 86% yield  
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(Scheme 3). The secondary alcohol of 12 was methylated using MeI and NaH in THF 
which resulted in methyl ether 13 in 71% yield. Silyl group in compound was 
deprotected by treatment with TBAF (1M) in THF at 0
o
C to afford alcohol 14 in 88% 
yield. Alcohol 14 was efficiently oxidised with IBX in DMSO/THF at room 
temperature to provide aldehyde 15 in 85% yield (Scheme 3).  
 
     According to the envisaged plan, the next task was a non-Evans syn aldol reaction 
of aldehyde 15 with versatile Crimmins chiral auxiliary 19. The chloro titanium 
enolate of 19 was formed by addition of 1.05 equiv. of TiCl4, followed by 1.1 equiv. 
of diisopropylethylamine and subsequent addition of aldehyde 15 gave alcohol 6 in 
70% yield (95:5 dr) (Scheme 4).  
Alcohol 6 was silylated by the action of TBSOTf and lutidine in CH2Cl2 at 0 
o
C to get 
compound 16 in 88% yield. The structure of 16 was confirmed by X-ray 
crystallography (Figure 3). Reduction of imide 16 with i-Bu2AlH in CH2Cl2 at -78 
o
C 
provided aldehyde 17 in 90% yield (Scheme 4). Aldehyde 17 underwent Evans syn 
aldol reaction with propionylthiazolidinethione 19, TiCl4 and (-)spartiene (2 equiv) in 
CH2Cl2 at 0 
o
C gave syn aldol product 18 in 63% yield (Scheme 4).  
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Figure 3. X-ray crystal structure of 16. Displacement ellipsoids are drawn at 30% 
probability level. 
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     Protection of secondary alcohol of 18 by treatment with MOM-Cl and DIPEA in 
CH2Cl2 0 
o
C resulted in 5 in 70% yield. The product was confirmed by its 
1
H NMR, 
13
C NMR and HRMS  spectral analysis. Reductive removal of the chiral auxiliary 
with DIBAL-H in CH2Cl2 at -78 
o
C provided the corresponding aldehyde 20 in 
excellent yield (90%) (Scheme 5).  Wittig reaction of the aldehyde 20 with 
Ph3P
+
C2H5I
-
 and n-BuLi in THF at -78 
o
C led to 21 as a mixture of stereoisomers in 
70% yield.  
     These stereoisomers were converted to single product 4 in 80% yield by 
hydrogenation of the double bond and benzyl deprotection with 10% Pd-C in EtOH in 
one pot (Scheme 5). The product 4 was confirmed by its 
1
H NMR, 
13
C NMR and 
HRMS  spectral analysis.  
 
 
     In summary, asymmetric aldol reaction has been utilized twice in a linear synthesis 
to generate all the required asymmetric carbons present in the polypropionate part of 
the target molecules (Hoiamides).  
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Chapter II:  
Chapter II describes an introduction to histone deacetylase (HDAC) inhibitors 
and synthesis of  Azumamide-E analogues. 
     Recently HDAC inhibitors have been focused on as potential drugs for the 
treatment of several diseases, including cancer. Thus HDAC inhibitors have potential 
as tools for life science studies and also as therapeutic agents for various intractable 
diseases. To date very few inhibitors of histone deacetylase are know in the art. There 
is thus a need to identify additional HDAC inhibitors and to identify the structural 
features required for potent HDAC inhibitor activity.  
     In continuation of our work in the synthesis of marine cyclic peptides, we were 
interested in the synthesis of azumamide E and their analogues. The azumamide E, in 
particular, has shown histone deacetylase (HDAC) inhibition at the lowest 
concentration among all other congeners of azumamides. We were fascinated both by 
its structural elegance as it incorporates a β-amino acid skeleton and by its novel 
biological profile. We synthesized azumamide E in a stereoselective manner. Along 
with azumamide E we synthesized azumamide E analogues by using our own β-sugar 
amino acid (β-SAA). The analogues which showed better biological activity profile 
towards HDAC inhibition, we are planned on the basis of the extensive reports of 
Kessler et al. Analogue A (2) was synthesized by incorporating β-amino acid (β-SAA) 
into the structural motif of azumamide E by replacing the D-alanine part. Analogue B 
(3) was synthesized by incorporating β-amino acid (β-SAA) into the structural motif 
of azumamide E by replacing the aliphatic chain (β-amino acid). Analogue C (4) has a 
triazole ring and analogue D (5) has azide acid functionality, which were prepared by 
using β-sugar amino acid. Analogues A (2) and B (3) are cyclic peptides whereas 
analogues C (4) and D (5) are linear compounds (Figure 1). Here we discuss the 
synthesis and HDAC inhibition of novel analogues of azumamide E. 
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     Our retrosynthetic analysis of azumamide E –SAA analogue A (2) is shown in 
scheme 6. First analogue 2 was disconnected at the amide bond between D-valine and 
β-amino acid segment. Tetrapeptide 6 could be elaborated from β-amino ester 8 and 
trimer 7. The trimer 7 in turn could be obtained form commercially available D-amino 
acids and known β-sugar amino ester 9 (Scheme 1). 
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     The D-N-Boc valine was coupled with the β-sugar amino methyl ester 9 under 
standard reaction conditions of 1-hydroxybenzotriazole (HOBt) and 1-ethyl-3-[3-
dimethylamino propyl] carbodiimide (EDCI) as coupling agents in anhydrous CH2Cl2 
as solvent to result in dipeptide 10 in 85% yield (Scheme 2). Dipeptide 10 under basic 
hydrolysis with LiOH.H2O in THF:H2O (7:3) was subsequently converted to free acid 
11 in 94% yield and used as such for the next reaction. 
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      The coupling of Boc protected dipeptide acid 11 and D-phenylalanine methyl ester 
under standard conditions in presence of EDCI, HOBt and DIPEA in dry CH2Cl2 gave 
tripeptide 12 in 74% yield (Scheme 2). Tripeptide 12 under basic hydrolysis with 
LiOH.H2O in THF:H2O (7:3) was subsequently converted to free acid 7 in 92% yield 
and used as such for the next reaction (Scheme 2). 
     The coupling of Boc protected tripeptide acid 7 and β-amino acid methyl ester 8 
under standard coupling conditions in presence of EDCI and HOBt in dry CH2Cl2 
gave tetrapeptide 6 in 72% yield (Scheme 3). 
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     The tetrapeptide 6 as tert-butyl carbamate was transformed to tert-butyl 
dimethylsilyl carbamate with TBSOTf and 2, 6-lutidine as a base. Then LiOH 
mediated double hydrolysis of tert-butyl dimethylsilyl carbamate and methyl ester 
functionalities provided free amino acid 13 in 81% yield, which was ready for 
macrolactmization (Scheme 3).  
     The tetrapeptide amino acid 13 was cyclized using 5 equiv. of EDCI-HOBt under 
high dilution conditions in CH2Cl2 to yield cyclic tetrapeptide 14 in 79% yield 
(Scheme 3). Compound 14 was confirmed by its 
1
H NMR, 
13
C NMR and HRMS  
spectral analysis. 
     In cyclic tetrapeptide 14, the MPM ether was cleaved under oxidative conditions 
with 2, 3-dichloro-5, 6-dicyanobenzoquinone (DDQ) in CH2Cl2:H2O which provided 
free alcohol 15 (Scheme 4). The free hydroxyl compound 15 on oxidation with 2, 2, 6, 
6-tetramethyl-1-piperidinyloxyl free radical (TEMPO)/ [bis-(acetoxy)-iodo] benzene 
(BAIB) in CH3CN and H2O provided azumamide E-SAA analogue (2) (Scheme 4). 
The structural confirmation was done by the aid of spectral analysis. 
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     Synthesis of azumamide E analogue -3, 4 and 5: 
     The N-terminal Boc-(DVal-DAla-DPhAla)-OCH3 16 was deprotected with TFA in 
dry CH2Cl2 to afford amine salt (Scheme 5), which was used as it is for the next 
reaction. Coupling of sugar acid azide 17 with amine derivative of 16 in presence of 
HOBt/EDCI/DIPEA in dry CH2Cl2 gave tripeptide 18 in 73% yield.  
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     The tripeptide azide ester 18 was transformed to amine with H2, 10% Pd-C in ethyl 
acetate. Then a LiOH mediated hydrolysis of methyl ester functionality led to provide 
free amino acid, which was ready for macrolactmization. Thus tripeptide amino acid 
was cyclized using 5 equiv of EDCI-HOBt under high dilution conditions in CH2Cl2 
to yield cyclic tetrapeptide 3 in 65% yield (Scheme 5). Compound 3 was confirmed 
by its 
1
H NMR, 
13
C NMR and HRMS  spectral analysis.  
 
 
     Tripeptide ester azide 18 when reacted with phenylacetylene 19 with Cu, CuSO4 in 
EtOH under refluxing conditions afforded triazole 4 in 74% yield (Scheme 6). 
Triazole 4 was confirmed by its 
1
H NMR, 
13
C NMR and HRMS  spectral analysis. 
     Tripeptide 18 under basic hydrolysis with LiOH.H2O in THF:H2O (7:3) was 
subsequently converted to free acid 5 in 90% yield (Scheme 7). Compound 5 was 
confirmed by its spectral analysis. 
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Biological activities: 
 
     To characterize whether the compounds are reliable and potential histone 
deacetylase inhibitors, the effect of the compounds on HDAC activity was determined 
by in vitro HDAC enzyme assays. Trichostatin A (TSA), a known histone deacetylase 
inhibitor, was used as positive control to compare the activity of compounds 1, 2 and 
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3. Parallel to its effect on cell cycle arrest, compounds 1, 2 and 3 were found to inhibit 
cellular histone deacetylase activity derived from cell lysate directly. The histone 
deacetylase activity was almost completely inhibited by the 20 μM compound 2 
(Table 1) in a cell-free system, other analogues 4 and 5 are not active in the same 
assay. 
     In summary, we have demonstrated a successful synthesis of azumamide E 
analogues 2, 3, 4 and 5. Azumamide E-SAA 2 and 3 had good activity based on 
preliminary biological data (HDAC inhibition).  
 
Chapter 3: Section-A: 
This section describes introduction to benzyne precursor (2-
(trimethylsilyl)phenyl trifluoromethanesulfonate) and synthesis of benzotriazoles  
via azide-benzyne  cycloaddition in a single step manner. 
     In recent times benzyne is generated simply from 2-(trimethylsilyl)phenyl 
trifluoromethanesulfonate under mild conditions and used in various cycloaddition 
reactions. This prompted us to study the practicability of obtaining benzotriazoles 
from 2-(trimethylsilyl)phenyl triflate. In continuation of our work on cycloadditions, 
herein we report an efficient synthesis of 1-alkyl benzotriazoles via cycloaddition of 
azide and benzyne under mild reaction conditions (Scheme 1). This reaction is 
analogous to the Huisgen 1,3-dipolar cycloaddition of azides and alkynes, which 
received significant applications after the development of copper(I)-catalyzed 
cycloaddition. 
 
     Accordingly, treatment of 2-(trimethylsilyl)phenyl trifluoromethanesulfonate 2 
with benzyl azide 1a and cesium fluoride in acetonitrile at room temperature afforded 
the corresponding benzotriazole in 82% yield (entry 1). With this success, a variety of 
alkyl azides were studied to investigate the scope of the cycloaddition reaction (Table 
1).  
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The results revealed that structurally different primary alkyl azides 1b to 1e were 
successfully participated in the cycloaddition reaction with 2, under described reaction 
conditions to provide corresponding 1-alkyl benzotriazoles 3b to 3e in good yield 
(entries 2–5). Similarly, reactions of various interesting secondary azide substrates 1f 
to 1i (derived from glucose di-acetonide, AZT and others) with 2 proceeded smoothly 
to afford furanolinked triazoles, having structural resemblance to nucleosides, 3h, 3i 
and others 3f, 3g (entries 6–9). Notably, several functionalities/protecting groups such 
as ester, ether, amide, tert-butylcarbamate, benzyl, p-methoxybenzyl, and acetonide 
were found to be stable under the present reaction conditions. Finally, reaction of 2 
with 1a and 1b was tested in the presence of tetrabutylammonium fluoride (TBAF), a 
metal-free fluorinating agent, and found to be efficient to afford the benzotriazoles 3a 
(62%) and 3b (65%), respectively, however with lower yields. The triazole 
compounds were confirmed by their 
1
H NMR, 
13
C NMR and HRMS  spectral analysis 
respectively.  
     In conclusion we have successfully developed an extremely facile, new and 
efficient method for the synthesis of 1-alkyl benzo triazoles in a single step by the 
cycloaddition of 2-(tri methylsilyl)phenyl trifluoromethanesulfonate with alkyl azide 
in presence of cesium fluoride at room temperature. 
 
Chapter III: Section-B:  
This section describes syntheis of triazolo-benzoxazepine derivatives and their 
biological evaluation. 
     The 1,3-dipolar cycloaddition reaction has also been used for the construction of 
various novel 1,2,3-triazolo heterocyclic compounds. Majority of 1,3-dipolar 
cycloaddition reactions are intermolecular reactions, while intramolecular version has 
remained limited. Further, intramolecular cycloaddition reaction provides fused 
triazoles, which are endowed with a wide range of biological activities.
 
Hence, in 
continuation to our ongoing research on ‘click chemistry’, we were interested in 
exploring the cycloaddition reaction in a intramolecular fashion for the formation of 
triazolo-benzoxazepine derivatives (Scheme 1). 
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     Starting from salicylaldehyde,
 
the desired azido-alkyne 1 was prepared in three 
steps as shown in scheme 2. In the first case, salicylaldehyde (3) was alkylated with 
propargyl bromide in presence of K2CO3 in acetone under refluxing conditions to 
obtain the o-propargylated aldehyde 4, in 92% yield. A reaction of 4 with RMgBr in 
dry diethyl ether at room temperature provided alcohols 5a-j in good yields.  
     To install the azide functionality, alcohol 5a was treated with TMSN3 in presence 
of BF3.Et2O (20 mol%) in CH2Cl2 at room temperature, which provided the azido-
alkyne 1a (98%) for the cycloaddition reaction. Having this azido-alkyne 1a in hand, 
intramolecular Cu(I)-catalyzed cycloaddition reaction was carried out for the 
synthesis of triazolo-[1,2,3]-benzoxazepine derivative 2a. Thus, azido-alkyne 1a was 
treated with copper(I)-catalyst in ethanol under reflux conditions to afford triazolo-
[1,2,3]-benzoxazepine 2a in 84% yield via intramolecular 1,3-dipolar cycloaddition 
reaction. The structure of compound 2a was determined by X-ray crystallographic 
studies (Figure 1) and fully characterized by its spectral analysis. 
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Figure 1. X-ray crystal structure of 2a. Displacement ellipsoids are drawn at 30% 
probability level and H atoms are shown as small spheres of arbitrary radii. 
 
     With success in the preparation of a novel heterocyclic scaffold, we were 
encouraged to prepare various substituted fused triazolo-[1,2,3]-benzoxazepine  
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derivatives. Accordingly, various azido-alkynes 1b to 1j were prepared from o-
propargylated aldehyde 4 following a similar sequence as shown in scheme 2. A 
reaction of 4 with various Grignard reagents provided the corresponding alcohols 5b 
to 5j in good yields. The conversion of these alcohols (5b-5j) to the corresponding 
azides 1b to 1j was also achieved without any difficulty under the above optimized 
conditions. All the prepared azido-alkynes (1b to 1j) were subjected to Cu(I)-
catalyzed intramolecular 1,3-dipolar cycloaddition reaction to afford the 
corresponding substituted fused triazolo-benzoxazepine derivatives  2b to 2j in good 
yields. The results are summarized in table 1. It is obvious that a wide variety of aryl 
(1a-1e), benzyl (1f), allyl (1g), alkyl (1h-1i) and alkynyl (1j) substituted azido-
alkynes successfully participated in the intramolecular cycloaddition reaction. 
     Finally, unsubstituted triazolo-benzoxazepine derivative 2k was also been prepared 
following the sequence shown in scheme 3, where aldehyde 4 was reduced to obtain 
the primary alcohol 5k using NaBH4 reduction followed by the azide formation and 
1,3- dipolar cycloaddition under optimized reaction conditions. 
 
     Further, a biological profile of the new fused [1, 2, 3] triazolo [5, 1-c] [1, 
4]benzoxazepines has been evaluated for anti-bacterial and anti-fungal activities. All 
the derivatives 2a to 2k were tested using the microtiter broth dilution method for in 
vitro antimicrobial studies and found that four compounds 2g to 2j were moderately 
active. However, one of the derivative 2h was found promising and showed a lowest 
MIC value of 93.75 μg/mL against both Gram-positive and Gram-negative bacteria 
like Staphylococcus aureus, Escherichia coli, Klebsiella planticola and also against 
Candida albicans, suggesting a broad spectrum nature of the antimicrobial activity. 
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     In conclusion we have successfully employed an intramolecular click chemistry of 
azido-alkynes to generate fused [1,2,3] triazolo[5,1-c][1,4] benzoxazepine derivatives. 
Additionally, a preliminary screening of the compounds obtained was carried out for 
anti-microbial activity. 
 
Chapter IV:  
This chapter describes introduction to peptidofoldamers and synthesis of   
oligomers of trans β-norbornene amino acid. 
     One of the important goals in peptide chemistry is to be able to design short 
peptides that can mimic some important aspect of protein structure or function. The 
present work focuses on the synthesis of stereo-specific oligomers of bicyclic exo-
trans-β-amino acids derived from norbornadiene and characterization of the 
secondary folding pattern is extensively studied by using NMR, MD and CD spectra. 
     Norbornadiene is a strained bicyclic compound used extensively in mechanistic 
organic chemistry and energy chemistry. However, this scaffold is not well utilized by 
bioorganic chemist. We have modified norbornadiene to an unusual amino acid and 
oligomerized alternatively with α-amino acids to obtain hybrid oligomers.  
     Syntheses of trans norbornene β-amino ester (monomer) 3 (Figure 1) is based on 
the following sequence. (i) Preparation of the racemic amino ester 1 by dipolar 
cycloaddition of norborna-2,5-diene and chlorosulphonyl isocyanate. (ii) Synthesis of 
N-tert-butyloxy carbonyl protected amino acid (iii) Separation of the enantiomers by 
using optical resolution method using enatiomerically pure phenylethylamine by 
induced crystallization. (iv) Esterification of the required enantiomer and 
epimerization by using K2CO3/MeOH. (v) Oligomerization. 
 
      [2+2] Dipolar cycloaddition of norborna-2,5-diene 4 and 
chlorosulphonylisocyanate gave exclusively exo isomer of tricyclic chlorosulphonyl  
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derivative, 5, in ether at 0 
o
C (Scheme 1).
 
The exo-chlorosulphonyl derivative was 
reduced with aq. Na2SO3 in ether as solvent and under basic conditions (by addition 
of small portion of aq. KOH) to afford the exo-azitidinone 6.  
 
     The tricyclic amide 6 was converted into cis-exo-amino methyl ester hydrochloride 
salt 7 by passing HCl gas into a solution of 6 (dry MeOH). The reaction continued to 
reach the reflux temperature furnished compound 7 in 80% yield. The crude methyl 
ester hydrochloride salt 7 was protected as its N-Boc derivative using triethylamine 
and (Boc)2O in CH2Cl2 at 0 
o
C under nitrogen atmosphere to give N-tert-
butyloxycarbonyl amino methyl ester 1 in 85% yield (Scheme 2). The N-Boc 
protected methyl ester 1 was treated with LiOH in THF:H2O (7:3) to realize the 
recemic acid compound 8 in 90% yield.  
 
 
     To arrive at the absolute stereochemistry of the newly created carboxylate and 
amine centers in 9, we have taken up a well established resolution method involving 
optically active phenylethylamines. In this method, the N-Boc protected acid 8 was 
converted into diastereomeric salts that they form with enantiomerically pure R-(+)- 
phenylethylamine by fractional crystallization (Scheme 3). 
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     Separation of enantiomers of N-Boc protected acid was obtained by fractional 
crystallization of diastereomeric salts that form with enantiomerically pure 
phenylethylamine. The amino acid derivative 8 and R-(+)-phenylethylamine was 
dissolved in ethyl acetate and the solution was kept overnight at room temperature for 
crystallization. The resulting salt was filtered off and recrystalized from ethyl acetate. 
The fractional recrystalization procedure was repeated until the value of optical 
rotation  [α]D25 = +16.0 (c 1, MeOH) become constant. Treatment of finally obtained 
resolved salt with 2N HCl afforded exo-(2S, 3R)-9 and optical rotation of this 
compound is [α]D25 = + 91.8 ( c 1, MeOH ). Compound 9 was further converted into 
it’s methyl ester 2, by using CH2N2 in ether.      
     Compound exo (2S, 3R)-2 was converted to it’s epimerized product trans-(2R, 3R) 
aminoester 3 by using K2CO3 and dry MeOH. The N-Boc protected trans amino 
methylester 3 was treated with LiOH in THF:H2O (7:3) to realize the acid compound 
10 in 95% yield (Scheme 4). 
 
     Having successfully synthesized new class of β-amino acid monomer of 
norbornene amino acid residue, the attention was then focused to synthesize a new 
class of hybrid peptides. 
     L-alanine 11 was treated with acetyl chloride in MeOH to furnish the methyl ester 
and the amine functionality was protected as N-Boc-derivative [Boc-(L-Ala)-OCH3] 
12 using (Boc)2O and triethylamine in CH2Cl2 in 85% yield. The N-terminal Boc-(L- 
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Ala)-OCH3 12 was deprotected with TFA in dry CH2Cl2 to afford amine salt 13 
(Scheme 5), which was used as it is for the next reaction. 
     L-Valine 14 was treated with acetyl chloride in MeOH to furnish the methyl ester 
and the amine functionality was protected as N-Boc-derivative [Boc-(L-Val)-OCH3] 
15 using (Boc)2O and triethylamine in CH2Cl2 in 84% yield. The N-terminal Boc-(L-
Val)-OCH3 15 was deprotected with TFA in dry CH2Cl2 to afford amine salt 16 
(Scheme 6), which was used as it is for the next reaction. 
  
     Accordingly, for the preparation of dipeptide 17, acid 10 and amine 13 were 
subjected to coupling under standard reaction conditions of 1-ethyl-3-(3-
(dimethylamino)propyl)-carbodiimide hydrochloride (EDCI), 1-hydroxybenzotriazole 
(HOBt) and diisopropylethylamine (DIPEA) in CH2Cl2 as solvent to result in 
dipeptide 17 in 65% yield (Scheme 7). 
     Similarly for the preparation of dipeptide 18, readily accessible acid 10 and amine 
16 were subjected to coupling under standard reaction conditions of 1-ethyl-3-(3- 
(dimethylamino)propyl)-carbodiimide hydrochloride (EDCI), 1-hydroxybenzotriazole 
(HOBt) and diisopropylethylamine (DIPEA) in CH2Cl2 as solvent to result in 
dipeptide  18 in 64% yield (Scheme 8). 
                                                                                            
                 Synopsis 
XXV 
 
 
      
     Hydrolysis of dipeptide 17 (Scheme 9) with LiOH in THF:MeOH:H2O (3:1:1) 
furnished acid 19 in quantative yield, which was used as such for the next reaction. 
The N-terminal dipeptide 18 was Boc deprotected with TFA in dry CH2Cl2 (Scheme 
9) to afford amine salt 20, which was used as it is for the next reaction. In a further 
study, coupling of 19 and 20 in presence of HOBt/EDCI/ DIPEA in dry CH2Cl2 gave 
tetrapeptide 21 (Scheme 9) in 60% yield. 
 
 
      
     After completion of the synthesis of tetrapeptide 21, next attempts were directed 
towards the synthesis of hexapeptide 24. Accordingly, dipeptide 18 was treated with 
LiOH in THF/MeOH/H2O (3:1:1) at room temperature to get its lithium salt followed 
by acidic workup to afford dipeptide acid 22 in quantative yield. The N-terminal  
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tetrapeptide 21 was Boc deprotected with TFA in dry CH2Cl2 (Scheme 10) to afford 
amine salt 23, which was used as it is for the next reaction. Synthesis of hexapeptide  
24 (Scheme 10) was achieved with 52 % yield on coupling of 22 with 23 under 
conventional peptide coupling (HOBt/EDCI/DIPEA) conditions in dry CH2Cl2 under 
inert atmosphere. 
 
 
In summary, we have synthesized novel hybrid and hetero oligopeptides (tetramer 21 
and hexamer 24) of trans--norbornene amino acid and L-Alanine, L-Valine residues. 
A detailed characterization of these oligomers has been carried out using NMR, CD 
and molecular dynamics simulation studies. The tetramer 21 and hexamer 24 
exhibited extended ribbon-like conformations stabilized by 8/7-membered inter-
residue H-bonds. 
